BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 12010826)

  • 1. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
    Morishima Y; Sasazuki T; Inoko H; Juji T; Akaza T; Yamamoto K; Ishikawa Y; Kato S; Sao H; Sakamaki H; Kawa K; Hamajima N; Asano S; Kodera Y
    Blood; 2002 Jun; 99(11):4200-6. PubMed ID: 12010826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
    Woolfrey A; Klein JP; Haagenson M; Spellman S; Petersdorf E; Oudshoorn M; Gajewski J; Hale GA; Horan J; Battiwalla M; Marino SR; Setterholm M; Ringden O; Hurley C; Flomenberg N; Anasetti C; Fernandez-Vina M; Lee SJ
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):885-92. PubMed ID: 20870028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation.
    Morishima Y; Kashiwase K; Matsuo K; Azuma F; Morishima S; Onizuka M; Yabe T; Murata M; Doki N; Eto T; Mori T; Miyamura K; Sao H; Ichinohe T; Saji H; Kato S; Atsuta Y; Kawa K; Kodera Y; Sasazuki T;
    Blood; 2015 Feb; 125(7):1189-97. PubMed ID: 25519752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
    Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
    Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
    Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
    Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation.
    Pidala J; Lee SJ; Ahn KW; Spellman S; Wang HL; Aljurf M; Askar M; Dehn J; Fernandez Viña M; Gratwohl A; Gupta V; Hanna R; Horowitz MM; Hurley CK; Inamoto Y; Kassim AA; Nishihori T; Mueller C; Oudshoorn M; Petersdorf EW; Prasad V; Robinson J; Saber W; Schultz KR; Shaw B; Storek J; Wood WA; Woolfrey AE; Anasetti C
    Blood; 2014 Oct; 124(16):2596-606. PubMed ID: 25161269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The impact of HLA high resolution typing mismatching of donor-recipient pairs on outcome of unrelated donor hematopoietic stem cell transplantation].
    He J; Xu C; Wu XJ; Bao XJ; Qiu QC; Yuan XN; Li Y; Shen HJ; Wu DP; Hong JL; Liu JH; DU HY; Zhang L; DU D; Lu J; Liu J
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):353-7. PubMed ID: 22781790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
    Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri IF; Folloder J; Ueno NT; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson BS; Champlin R
    Biol Blood Marrow Transplant; 2000; 6(2A):190-7. PubMed ID: 10816027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell Transplantation.
    Kanda J; Ichinohe T; Fuji S; Maeda Y; Ohashi K; Fukuda T; Miyamura K; Iwato K; Eto T; Nakamae H; Kobayashi N; Mori T; Mori S; Morishima Y; Atsuta Y; Kanda Y;
    Biol Blood Marrow Transplant; 2015 Feb; 21(2):305-11. PubMed ID: 25464119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors.
    Leung WH; Turner V; Richardson SL; Benaim E; Hale G; Horwitz EM; Woodard P; Bowman LC
    Hum Immunol; 2001 Apr; 62(4):399-407. PubMed ID: 11295473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan Marrow Donor Program.
    Sasazuki T; Juji T; Morishima Y; Kinukawa N; Kashiwabara H; Inoko H; Yoshida T; Kimura A; Akaza T; Kamikawaji N; Kodera Y; Takaku F
    N Engl J Med; 1998 Oct; 339(17):1177-85. PubMed ID: 9780337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience.
    Petersdorf EW; Kollman C; Hurley CK; Dupont B; Nademanee A; Begovich AB; Weisdorf D; McGlave P
    Blood; 2001 Nov; 98(10):2922-9. PubMed ID: 11698272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of HLA-DQ as a transplantation antigen.
    Petersdorf EW; Longton GM; Anasetti C; Mickelson EM; Smith AG; Martin PJ; Hansen JA
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15358-63. PubMed ID: 8986816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.
    Flomenberg N; Baxter-Lowe LA; Confer D; Fernandez-Vina M; Filipovich A; Horowitz M; Hurley C; Kollman C; Anasetti C; Noreen H; Begovich A; Hildebrand W; Petersdorf E; Schmeckpeper B; Setterholm M; Trachtenberg E; Williams T; Yunis E; Weisdorf D
    Blood; 2004 Oct; 104(7):1923-30. PubMed ID: 15191952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation.
    Petersdorf EW; Hansen JA; Martin PJ; Woolfrey A; Malkki M; Gooley T; Storer B; Mickelson E; Smith A; Anasetti C
    N Engl J Med; 2001 Dec; 345(25):1794-800. PubMed ID: 11752355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients.
    Martin PJ; Rowley SD; Anasetti C; Chauncey TR; Gooley T; Petersdorf EW; van Burik JA; Flowers ME; Storb R; Appelbaum FR; Hansen JA
    Blood; 1999 Oct; 94(7):2192-9. PubMed ID: 10498588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
    Li S; Kawata H; Katsuyama Y; Ota M; Morishima Y; Mano S; Kulski JK; Naruse T; Inoko H
    Tissue Antigens; 2004 Apr; 63(4):362-8. PubMed ID: 15009808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DPB1 mismatch induces a graft-versus-leukemia effect without severe acute GVHD after single-unit umbilical cord blood transplantation.
    Yabe T; Azuma F; Kashiwase K; Matsumoto K; Orihara T; Yabe H; Kato S; Kato K; Kai S; Mori T; Morishima S; Satake M; Takanashi M; Nakajima K; Morishima Y;
    Leukemia; 2018 Jan; 32(1):168-175. PubMed ID: 28652579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
    Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.
    Ringdén O; Remberger M; Carlens S; Hagglund H; Mattsson J; Aschan J; Lönnqvist B; Klaesson S; Winiarski J; Dalianis T; Olerup O; Sparrelid E; Elmhorn-Rosenborg A; Svahn BM; Ljungman P
    Transplantation; 1998 Sep; 66(5):620-5. PubMed ID: 9753343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.